Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment

Upcoming event

May 30, 2022

Annual General Meeting

Latest presentation

Latest Report

April 26, 2022

Q1 Report 2022

Calendar and upcoming reports

May 30, 2022

Annual General Meeting

August 19, 2022

Half-year report January - June

November 8, 2022

Interim report January - September

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com